EUVIMEDSkopri EUVIMED
Open access

Oct4, Sox2, Klf4, c-My (OSKM) gene therapy in the hypothalamus prolongs fertility and ovulation in female rats

Maria D Gallardo, Mauricio Girard, Enrique L Portiansky, Rodolfo G Goya

Aging · 2025

DOI: 10.18632/aging.206191 ↗

At a glance

Journal article in Aging, 2025. Written by Maria D Gallardo and 3 co-authors. Institution: School of Medicine, National University of La Plata (UNLP), La Plata, Argentina. Major MEDLINE topics: Hypothalamus, Genetic Therapy, Fertility, Ovulation. Cited 1 times so far (Crossref); 24 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

In middle-aged (MA) female rats, we have demonstrated that intrahypothalamic gene therapy for insulin-like growth factor-I (IGF-I) extends the regular cyclicity of the animals beyond 10 months (the age at which MA rats stop ovulating). Here, we implemented long-term OSKM gene therapy in the hypothalamus of young female rats. The main goal was to extend fertility in the treated animals. We constructed an adenovector that harbors the GFP gene as well as 4 Yamanaka genes. An adenovector that only carries the gene for GFP or DsRed was used as control. At 4 months of age 12 female rats received an intrahypothalamic injection of our OSKM vector (treated rats); 12 control rats received a vector expressing a marker gene (control rats). At 9.3 months of age control and treated rats were mated with young males. A group of 12 young intact female rats was also mated. The rate of pregnancy recorded was 83%, 8.3 and 25% for young, MA control and MA treated animals, respectively. Pup body weight (BW) at weaning was significantly higher in the MA OSKM rats than in MA controls. At the age of estropause (10 months), OSKM treated females still showed regular estrous cycles. The particular significance of the present results is that, for the first time, it is shown that long-term OSKM gene therapy in the hypothalamus is able to extend the functionality of such a complex system as the hypothalamo-pituitary-ovarian axis.

Subjects

MeSH terms (MEDLINE)

HypothalamusGenetic TherapyFertilityOvulationAnimalsFemaleRatsPregnancyOctamer Transcription Factor-3Kruppel-Like Transcription FactorsSOXB1 Transcription FactorsKruppel-Like Factor 4

Author keywords

Yamanaka genesfertilitygene therapyhypothalamusovulationreproductive aging

Substances

Klf4 protein, ratOctamer Transcription Factor-3Kruppel-Like Transcription FactorsSOXB1 Transcription FactorsKruppel-Like Factor 4

Authors and institutions

  • School of Medicine, National University of La Plata (UNLP), La Plata, Argentina.
  • Image Analysis lab; School of Veterinary Sciences, National University of La Plata, La Plata, Argentina.
  • Biomedical Research and Longevity Society, Fort Lauderdale, FL 33309, USA.

Cite

APA

Gallardo, M. D., Girard, M., Portiansky, E. L., & Goya, R. G. (2025). Oct4, Sox2, Klf4, c-My (OSKM) gene therapy in the hypothalamus prolongs fertility and ovulation in female rats. Aging. https://doi.org/10.18632/aging.206191

Vancouver

Gallardo MD, Girard M, Portiansky EL, Goya RG. Oct4, Sox2, Klf4, c-My (OSKM) gene therapy in the hypothalamus prolongs fertility and ovulation in female rats. Aging. 2025. doi:10.18632/aging.206191

BibTeX
@article{Gallardo2025,
  author = {Gallardo, Maria D and Girard, Mauricio and Portiansky, Enrique L and Goya, Rodolfo G},
  title = {Oct4, Sox2, Klf4, c-My (OSKM) gene therapy in the hypothalamus prolongs fertility and ovulation in female rats},
  journal = {Aging},
  year = {2025},
  doi = {10.18632/aging.206191}
}
Start for free →